MEMORIAL DAY OFFER 50% OFF Premium Subscription Order Now MEMORIAL DAY 50% OFF Subscription >>

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Alnylam Pharmaceuticals Stock Forecast

NASDAQ:ALNY BUY SELL

$127.77 (1.73%)

Volume: 557.786k

Closed: May 27, 2022

Hollow Logo Score: -2.543

Alnylam Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:ALNY
$127.77 (1.73%)

Volume: 557.786k

Closed: May 27, 2022

Score Hollow Logo -2.543

Alnylam Pharmaceuticals Stock Price (Quote) NASDAQ:ALNY

$127.77 ( 1.73% ) Friday, 27th May 2022

Range Low Price High Price Comment
30 days $117.58 $157.67 Friday, 27th May 2022 ALNY stock ended at $127.77. This is 1.73% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 5.41% from a day low at $121.36 to a day high of $127.92.
90 days $117.58 $180.14
52 weeks $117.58 $212.00

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2022-05-27 $125.37 $127.92 $121.36 $127.77 557 786
2022-05-26 $127.19 $129.06 $125.02 $125.60 330 291
2022-05-25 $126.67 $127.83 $124.83 $126.75 916 561
2022-05-24 $128.59 $128.59 $124.80 $127.05 536 433
2022-05-23 $132.07 $133.29 $128.31 $129.58 910 311
2022-05-20 $129.82 $133.13 $129.22 $132.27 1 168 848
2022-05-19 $128.47 $131.35 $127.34 $129.36 744 136
2022-05-18 $126.44 $130.90 $125.52 $128.31 660 860
2022-05-17 $127.41 $130.10 $125.66 $129.31 724 151
2022-05-16 $125.74 $127.91 $123.27 $124.87 939 591
2022-05-13 $124.01 $128.77 $124.00 $126.47 740 287
2022-05-12 $119.30 $123.14 $117.58 $121.33 1 054 714
2022-05-11 $126.47 $129.16 $119.58 $120.42 951 489
2022-05-10 $126.21 $131.06 $124.34 $128.18 1 022 182
2022-05-09 $132.11 $132.21 $120.16 $122.52 1 427 313
2022-05-06 $135.16 $136.50 $132.13 $134.75 602 064
2022-05-05 $142.74 $142.74 $134.51 $136.74 798 839
2022-05-04 $143.72 $144.98 $138.73 $143.43 948 745
2022-05-03 $140.17 $143.28 $139.45 $142.89 694 623
2022-05-02 $131.59 $139.15 $131.59 $139.05 850 561
2022-04-29 $142.04 $143.75 $132.45 $133.43 1 444 993
2022-04-28 $150.36 $151.31 $138.52 $143.16 1 913 613
2022-04-27 $155.74 $157.67 $153.89 $154.92 1 056 713
2022-04-26 $160.15 $161.11 $154.58 $155.00 986 582
2022-04-25 $161.11 $164.33 $157.35 $162.07 904 768
2022-04-22 $168.34 $169.00 $166.43 $167.04 250 271
2022-04-21 $168.73 $171.84 $168.30 $168.75 878 100
2022-04-20 $164.28 $168.32 $160.48 $167.95 528 200
2022-04-19 $157.48 $161.64 $156.99 $161.20 638 300
2022-04-18 $166.16 $166.74 $155.85 $156.68 654 800
2022-04-14 $168.43 $170.04 $167.30 $167.30 339 761
2022-04-13 $160.79 $168.59 $158.81 $168.59 485 026
2022-04-12 $158.46 $165.15 $157.79 $159.54 590 526
2022-04-11 $163.80 $165.27 $157.18 $157.30 475 420
2022-04-08 $163.00 $168.48 $162.99 $163.42 686 300
2022-04-07 $157.95 $168.04 $157.66 $162.25 1 047 500
2022-04-06 $158.02 $160.40 $157.20 $158.47 736 200
2022-04-05 $161.25 $165.98 $159.47 $159.91 661 400
2022-04-04 $167.26 $167.69 $160.46 $161.77 1 507 600
2022-04-01 $166.41 $180.14 $164.01 $169.28 1 711 827
2022-03-31 $166.56 $168.57 $163.05 $163.27 521 715
2022-03-30 $167.41 $169.87 $165.02 $165.25 394 466
2022-03-29 $163.63 $166.74 $163.57 $166.74 698 100
2022-03-28 $163.46 $164.13 $158.85 $161.65 664 700
2022-03-25 $165.00 $165.00 $161.36 $163.81 539 700
2022-03-24 $164.26 $164.26 $160.59 $163.70 865 300
2022-03-23 $162.87 $164.50 $161.91 $162.35 612 600
2022-03-22 $163.57 $164.14 $161.22 $163.83 693 223
2022-03-21 $164.17 $166.00 $161.75 $162.43 539 150
2022-03-18 $164.73 $166.43 $163.45 $165.25 1 032 444

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. The company’s clinical development programs include Patisiran and Revusiran, which are in Phase III clinical trials for the treatment of transthyretin amyloidosis (ATTR); ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR for the treatment of various forms of ATTR amyloidosis; Fitusiran, an... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT